TGFβ in fibroproliferative diseases in the eye

Frontiers in Bioscience - Scholar

Volumn 1 S, Issue 1, 2009, Pages 376-390

  Saika, Shizuya ^a   Yamanaka, Osamu ^a   Okada, Yuka ^a   Tanaka, Sai Ichi ^a   Miyamoto, Takeshi ^a   Sumioka, Takayoshi ^a   Kitano, Ai ^a   Shirai, Kumi ^a   Ikeda, Kazuo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Epithelial mesenchymal transition; Eye; Gene transfer.; Myofibroblast; Review; Signal transduction; Smad; Tissue fibrosis; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

EPITHELIUM CELL; EYE DISEASE; FIBROSIS; HUMAN; MESODERM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

EPITHELIAL CELLS; EYE DISEASES; FIBROSIS; HUMANS; MESODERM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77954485140     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/e32     Document Type: Article

References (127)

1. Piek, E., Ju, W. J., Heyer, J., Escalante-Alcalde, D., Stewart, C. L., Weinstein, M., Deng, C., Kucherlapati, R., Bottinger, E. P., Roberts, A. B: Functional characterization of transforming growth factor b signaling in Smad2-and Smad3-deficient fibroblasts. J Biol Chem 276, 19945-19953 (2001)
2. Massague, J: Integration of Smad and MAPK pathways: a link and a linker revisited. Genes 17, 2993-2997 (2003) (Pubitemid 38040762)
3. Yang, X., Letterio, J. J., Lechleider, R. J., Chen, L., Hayman, R., Gu, H., Roberts, A. B., Deng, C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β EMBO J 18, 1280-1291 (1999) (Pubitemid 29110312)
4. Shi, Y., Massague, J: Mechanisms of TGF-P signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003) (Pubitemid 36724933)
5. Massague, J., Gomis, R. R: The logic of TGFp signaling. FEBS Lett 580, 2811-2820 (2006)
6. Itoh, S., ten Dijke, P: Negative regulation of TGF-P receptor/Smad signal transduction. Curr Opin Cell Biol 19, 176-184 (2007) (Pubitemid 46386411)
7. Ten Dijke, P., Goumans, M. J., Itoh, F., Itoh: SRegulation of cell proliferation by Smad proteins. J Cell Physiol 191, 1-16 (2002) (Pubitemid 34195213)
8. Yang, Y. C., Piek, E., Zavadil, J., Liang, D., Xie, D., Heyer, J., Pavlidis, P., Kucherlapati, R, Roberts, A. B., Böttinger, E. P: Hierarchical model of gene regulation by transforming growth factor b. Proc Natl Acad Sci USA 100, 10269-10274 (2003) (Pubitemid 37071868)
9. Saika, S., Myamoto, T, Yamanaka, O., Kato, T, Ohnishi, Y, Flanders, K. C., Ikeda, K., Nakajima, Y, Kao, W. W.-Y, Sato, M., Muragaki, Y, Ooshima: ATherapeutic effect of topical administration of SN50, an inhibitor of NF-kB, in treatment of corneal alkali burns in mice. Am J Pathol 166, 1393-1403 (2005) (Pubitemid 40586510)
10. Yamanaka, O., Saika, S., Ohnishi, Y, Kim-Mtsuyama S, Ikeda K: Inhibition of p38MAP kinase suppresses fibrogenic reaction in conjunctiva in mice. Mol Vision 13:1730-9. (2007) (Pubitemid 47471191)
11. Ulloa, L., Doody, J., Massague, J: Inhibition of transforming growth factor-b/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397, 710-713 (1999)
12. Bitzer, M, von Gersdorff, G, Liang, D, Dominguez-Rosales, A., Beg, A. A., Rojkind, M., Bottinger, E. P: A mechanism of suppression of TGF-p/SMAD signaling by NF-KB/RelA. Genes Dev 14, 187-97 (2000) (Pubitemid 30070984)
13. Yamanaka, O., Saika, S., Okada, Y, Ooshima, A., Ohnishi, Y: Effects of interferon on human subconjunctival fibroblasts in the presence of TGFp1: reversal of TGFpstimulated collagen production. Graefes Arch Clin Exp Ophthalmol 241, 116-124 (2003) (Pubitemid 36747799)
14. Weng, H, Mertens, P. R., Gressner, A. M., Dooley, S: IFN-Y abrogates profibrogenic TGF-P signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol. 46, 295-303 (2007) (Pubitemid 44959156)
15. Martin, P: Wound healing-aiming for perfect skin regeneration. Science 276, 75-81 (1997) (Pubitemid 27161246)
16. Martin, P., Parkhurst, S. M: Parallels between tissue repair and embryo morphogenesis. Development 131, 3021-34 (2004) (Pubitemid 39077428)
17. Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein. M., Letterio, J. L., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., Roberts, A. B: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1, 260-266 (1999) (Pubitemid 129495775)
18. Denton, CP., Zheng, B., Evans, L. A., et al: Fibroblastspecific expression of a kinase-deficient type II transforming growth factor β (TGFβ) receptor leads to paradoxical activation of TGFβ signaling pathways with fibrosis in transgenic mice. J Biol Chem 278, 25109-25119 (2003) (Pubitemid 37548675)
19. Albanis, E., Friedman, S. L: Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 5, 315-334 (2001) (Pubitemid 32472561)
20. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., Brown, R. A: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349-363 (2002) (Pubitemid 34619269)
21. Friedman, S. L: Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1, 98-105 (2004) (Pubitemid 40823677)
22. Gabbiani, G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200, 500-503 (2003) (Pubitemid 36818250)
23. Wynn, T. A: Fibrotic diseases. Review series. J Clin Invest 117, 524-586 (2007)
24. Evans, R. A., Tian, Y. C., Steadman, R., Phillips, A. O: TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 282, 90-100 (2003) (Pubitemid 36262031)
25. Flanders, K. C., Major, C. D., Arabshahi, A., Aburime, E. E., Okada, M. H., Fujii, M., Blalock, T. D., Schultz, G. S., Sowers, A., Anzano, M. A., Mitchell, J. B., Russo, A., Roberts, A. B: Interference with transforming growth factor-b/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol 163, 2247-2257 (2003) (Pubitemid 37466469)
26. Roberts, A. B., Russo, A., Felici, A., Flanders, K. C: Smad3: a key player in pathogenetic mechanisms dependent on TGF-β. Ann N Y Acad Sci 995, 1-10 (2003) (Pubitemid 36706609)
27. Hinz, B., Gabbianim G: Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost 90, 993-1002 (2003) (Pubitemid 38004416)
28. Quan, T. E., Cowper, S. E., Bucala, R: The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 8, 145-150 (2006) (Pubitemid 44623983)
29. Willis, B. C., du Bois, R. M., Borok, Z: Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 3, 377-382 (2006) (Pubitemid 43845416)
30. Li, J., Deane, J. A., Campanale, N. V., Bertram, J. F., Ricardo, S. D: The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 25, 697-706 (2007) (Pubitemid 46354229)
31. Nieto, MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3, 155-166 (2002)
32. Kawaguchi, R., Saika, S., Wakayama, M., Ooshima, A., Ohnishi, Y., Yabe, H: Extracellular matrix components in a case of retrocorneal membrane associated with syphilitic interstitial keratitis. Cornea. 20, 100-3 (2001) (Pubitemid 32038164)
33. Sato, M., Muragaki, Y., Saika, S., Roberts, AB., Ooshima, A: Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointestinal fibrosis induced by unilateral obstruction. J Clin Inves 112, 1486-1492 (2003)
34. Kalluri, R., Neilson, E. G: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112, 1776-1784 (2003) (Pubitemid 38063698)
35. Oft, M., Akhurst, R. J., Balmain, A: Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Bio l 4, 487-494 (2002) (Pubitemid 34752433)
36. Saika S: Therapeutic effects of adenovirus-mediated gene transfer of TGF-β signal antagonists on undesirable epithelial-mesenchymal transition and neovascularization. In: Jakowlew, S. B., (ed.) TGF-β in Cancer Therapy. Humana Press, Totawa, NJ, USA, 367-381 (2007)
37. Huber, M. A., Azoitei, N., Baumann, B., Grunert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., Wirth, T: NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114, 569-81 (2004) (Pubitemid 39572107)
38. Lee, J. M., Dedhar, S., Kalluri, R., Thompson, E. W: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172, 973-81 (2006)
39. Saika, S: TGF-β signal transduction in corneal wound healing as a therapeutic target. Cornea. 23, S25-S30 (2004) (Pubitemid 39458540)
40. Saika, S: TGFβ pathobiology in the eye. Lab Invest 86, 106-115 (2006)
41. Saika, S., Kono-Saika, S., Liu, C-Y., Azhar, M., Sanford, L. P., Doetschman, T., Gendron, R. L, Kao, C. W.-C., Kao, W. W.-Y: TGFβ2 in corneal morphogenesis during mouse embryonic development. Dev Biol 240, 419-432 (2001) (Pubitemid 34056501)
42. Imanishi, J., Kamiyama, K., Iguchi, I., Kita, M., Sotozono, C., Kinoshita, S: Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 19, 113-129 (2000)
43. Suzuki, K., Saito, J., Yanai, R., Yamada, N., Chikama, T., Seki, K., Nishida, T: Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res 22, 113-133 (2003) (Pubitemid 36246530)
44. Fini, M. E: Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res 18, 529-551 (1999) (Pubitemid 29126966)
45. Nishida, K., Yamato, M., Hayashida, Y., Watanabe, K., Yamamoto, K., Adachi, E., Nagai, S., Kikuchi, A., Maeda, N., Watanabe, H., Okano, T., Tano, Y: Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 351, 1187-1196 (2004) (Pubitemid 39296306)
46. Jinza, K., Saika, S., Kin, K., Ohnishi, Y: Relationship between formation of a filtering bleb and an intrascleral aqueous drainage route after trabeculectomy: evaluation using ultrasound biomicroscopy. Ophthalmic Res 32, 240-243 (2000)
47. Kaimori, A., Potter, J., Kaimori, J. Y., Wang, C., Mezey, E., Koteish, A: Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282, 22089-22101 (2007) (Pubitemid 47195788)
48. Siriwardena, D., Khaw, P. T., King, A. J., Donaldson, M. L., Overton, B. M., Migdal, C., Cordeiro, M. F: Human antitransforming growth factor β2 monoclonal antibody - a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. Ophthalmology 109, 427-31 (2002) (Pubitemid 34184907)
49. Jampel, H. D., Roche, N., Stark, W. J., Roberts, A. B: Transforming growth factor-β in human aqueous humor. Curr Eye Res 9, 963-969 (1990) (Pubitemid 20372121)
50. Tripathi, R. C., Li, J., Chan, W. F., Tripath, B. J: Aqueous humor in glaucomatous eyes contains an increased level of TGF-b2. Exp Eye Res 59, 723-7 (1994)
51. Saika, S., Yamanaka, O., Baba, Y., Kawashima, Y., Shirai, K., Miyamoto, T., Okada, Y., Ohnishi, Y., Ooshima, A: Accumulation of latent transforming growth factor-β binding protein and TGF β1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts. Greafes Arch Clin Exp Ophthalmol 239, 234-241 (2001) (Pubitemid 32422032)
52. Sakamoto, T., Ueno, H., Sonoda, K., Hisatomi, T., Shimizu, K., Ohashi, H., Inomata, H: Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Ther 7, 1915-1924 (2000)
53. Saika, S., Okada, Y., Miyamoto, T., Yamanaka, O., Ohnishi, Y., Ooshima, A., Liu, C.-Y., Weng, D., Kao, W. W.-Y: Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 45, 100-109 (2004) (Pubitemid 38055674)
54. Saika, S., Ikeda, K., Yamanaka, O., Miyamoto, T., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Nakajima, Y, Kao, WW-Y, Flanders, K. C, Roberts, A. B: Expression of Smad7 in mouse eyes accelerates healing of corneal tissue following exposure to alkali. Am J Pathol 166, 1405-1418 (2005) (Pubitemid 40586511)
55. Chinetti, G., Fruchart, JC, Staels, B: Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49, 497-505 (2000)
56. Clark, RB: The role of PPARs in inflammation and immunity. J Leukoc Biol 71, 388-400 (2002)
57. Delerive, P., Fruchart, J. C., Staels, B: Peroxisome proliferator- activated receptors in inflammation control. J Endocrinol 169, 453-459 (2001) (Pubitemid 32536978)
58. Saika, S., Yamanaka, O., Okada, Y, Miyamoto, T., Kitano, A., Flanders, K. C., Ohnishi, Y, Nakajima, Y, Kao, W. W.-Y., Ikeda, K: Effect of overexpression of ppary on the healing process of corneal alkali burn in mice. Am J Physiol Cell Physiol 293, C75-86 (2007) (Pubitemid 47105026)
59. Yamamoto, Y, Gaynor, R. B: Therapeutic potential of inhibition of the NF-kB pathway in the treatment of inflammation and cancer. J Clin Invest 107, 135-142 (2001) (Pubitemid 32096826)
60. Piguet, P. F., Vesin, C: Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 7, 515-518 (1994) (Pubitemid 24099014)
61. Kuroki, M., Noguchi, Y., Shimono, M., Tomono, K., Tashiro, T., Obata, Y., Nakayama, E., Kohno, S: Repression of bleomycin-induced pneumopathy by TNF. J Immunol 170, 567-574 (2003) (Pubitemid 36026184)
62. Saika, S., Ikeda, K., Yamanaka, O., Flanders, K. C., Okada, Y., Miyamoto, T., Kitano, A., Ooshima, A., Nakajima, Y., Ohnishi, Y., Kao, W. W: Loss of tumor necrosis factor a potentiates transforming growth factor b-mediated pathogenic tissue response during wound healing. Am J Pathol 168, 1848-1860 (2006) (Pubitemid 43825305)
63. Fujita, S, Saika, S., Kao, W. W.-Y., Fujita, K., Miyamoto, T., Ikeda, K., Nakajima, Y., Ohnishi, Y: Endogenous TNFa blocks neovascularization in corneal stroma in mice. Invest Ophthalmol Vis Sci 48, 3051-3055 (2007) (Pubitemid 351261147)
64. Apple, D. J., Solomon, K. D., Tetz, M. R., Assia, E. I., Holland, E. Y., Legler, U. F., Tsai, J. C., Castaneda, V. E., Hoggatt, J. P., Kostick, A. M: Posterior capsule opacification. Surv Ophthalmol 37, 73-116 (1992)
65. Emery, J: Capsular opacification after cataract surgery. Curr Opin Ophthalmol 10, 73-80 (1999) (Pubitemid 29077833)
66. Olson, R. J., Mamalis, N., Werner, L., Apple, D. J: Cataract treatment in the beginning of the 21st century. Am J Ophthalmol 136, 146-54 (2003) (Pubitemid 36794507)
67. Saika, S: I ntraocular lens: Biocompatibility related to lens epithelial cells. Prog Retinal Eye Res 23, 283-305 (2004)
68. Wormstone, I. M: Posterior capsule opacification: a cell biological perspective. Exp Eye Res 74, 337-347 (2002) (Pubitemid 34948380)
69. de Iongh, R. U., Wederell, E., Lovicu, F. J., McAvoy, J. W: Transforming growth factor-β-induced epithelialmesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 179, 43-55 (2005) (Pubitemid 40976288)
70. Saika, S., Okada, Y., Miyamoto, T., Ohnishi, Y., Ooshima, A., McAvoy, J. W: Smad translocation and growth suppression in lens epithelial cells by endogenous TGFβ2 during wound repair. Exp Eye Res 72, 679-686 (2001) (Pubitemid 32977214)
71. Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C. H., Moustakas, A: TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelialmesenchymal cell transition. Mol Biol Cell 16, 1987-2002 (2005) (Pubitemid 40471965)
72. Banh, A., Deschamps, P. A., Gauldie, J., Overbeek, P. A., Sivak, J. G., West-Mays, J. A: Lens-specific expression of TGF-β induces anterior subcapsular cataract formation in the absence of Smad3. Invest Ophthalmol Vis Sci 47, 3450-60, (1996)
73. Robertson, J. V., Nathu, Z., Najjar, A., Dwivedi, D., Gauldie, J., West-Mays, J. A: Adenoviral gene transfer of bioactive TGFβ1 to the rodent eye as a novel model for anterior subcapsular cataract. Mol Vis 13, 457-69 (2007) (Pubitemid 46502438)
74. Shirai, K., Saika, S., Tanaka, T., Okada, Y., Flanders, K. C., Ooshima, A., Ohnishi, Y: A new model of anterior subcapsular cataract: involvement of TGFβ/Smad signaling. Mol Vis 12, 681-691 (2006) (Pubitemid 43905816)
75. Bhowmick, N. A., Ghiassim, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., Moses, H. L: Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12, 27-36 (2001) (Pubitemid 32060576)
76. Cho, HJ., Yoo, J: Rho activation is required for transforming growth factor-β-induced epithelialmesenchymal transition in lens epithelial cells. Cell Biol Int 31:1225-1230 (2007) (Pubitemid 47030990)
77. Cho, HJ., Baek, K. E., Saika, S., Jeong, M. J., Yoo, J: Snail is required for transforming growth factor-b-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 353, 337-343 (2007) (Pubitemid 46014570)
78. Walker, J. L., Wolff, I. M., Zhang, L., Menko, A. S: Activation of SRC kinases signals induction of posterior capsule opacification. Invest Ophthalmol Vis Sci 48, 2214-2223 (2007) (Pubitemid 351261297)
79. Uemura, M., Swenson, E. S., Gaca, M. D., Giordano, F. J., Reiss, M., Wells, R. G: Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alphasmooth muscle actin organization. Mol Biol Cell 16, 4214-4224 (2005) (Pubitemid 41262890)
80. Iozzo, RV: The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274, 18843-18846 (1999) (Pubitemid 29314072)
81. Saika, S., Shiraishi, A., Saika, S., Liu, C.-Y., Funderburgh, J. L., Kao, C. W.-C., Converse, RL., Kao, W. W.-Y: Role of lumican in the corneal epithelium during wound healing. J Biol Chem 275, 2607-2612 (2000) (Pubitemid 30082027)
82. Saika, S., Miyamoto, T., Tanaka, S., Tanaka, T., Ishida, I., Ohnishi, Y., Ooshima, A., Ishiwata, T., Assano, G., Chikama, T-I., Shiraishi, A., Liu, C-Y., Kao, C. W.-C., Kao, W. W.-Y: Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 44, 2094-2102 (2003) (Pubitemid 36520304)
83. Saika, S., Miyamoto, T., Ishida, I., Ohnishi, Y., Ooshima, A: Osteopontin: a component of matrix in capsular opacification and subcapsular cataract. Invest Ophthalmol Vis Sci 44, 1622-1628 (2003) (Pubitemid 36378590)
84. Saika, S., Shirai, K., Yamanaka, O., Miyazaki, K., Okada, Y., Kitano, A., Flanders, K. C., Kon, S., Uede, T., Kao, W. W.-Y., Rittling, S., Denhardt, D: Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium. Lab Invest 87, 130-138 (2007)
85. Shintani, Y., Maeda, M., Chaika, N., Johnson, K. R., Wheelock, M. J: Collagen I Promotes EMT in Lung Cancer Cells via TGF-β3 Signaling. Am J Respir Cell Mol Biol 38, 95-104 (2008)
86. Ursell, P. G., Spalton, D. J., Pande, M. V., Hollick, E. J., Barman, S., Boyce, J., Tilling, K: Relationship between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg 24, 352-60 (1998) (Pubitemid 28185611)
87. Miyamoto, T., Saika, S., Okada, Y., Ishida-Nishikawa, I., Sumioka, T., Fujita, N., Ohnishi, Y: Topical exposure of mitomycin C reduces opacification of the residual anterior lens capsule and lenticular regeneration after vitrectomy and lensectomy in rabbits. Graefes Arch Clin Exp Ophthalmol 242, 327-331 (2004) (Pubitemid 38647607)
88. Maloof, A. J., Pandey, S. K., Neilson, G., Milverton, E. J: Selective death of lens epithelial cells using demineralized water and Triton X-100 with PerfectCapsule sealed capsule irrigation: a histological study in rabbit eyes. Arch Ophthalmol 123, 1378-1384 (2005) (Pubitemid 41429738)
89. Kroll, P., Rodrigues, E. B., Hoerle, S: Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 221, 78-94 (2007) (Pubitemid 46465433)
90. Grisanti, S., Guidry, C: Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 36, 391-405 (1995)
91. Casaroli-Marano, R. P., Pagan, R., Vilaro, S: Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40, 2062-72 (1999) (Pubitemid 29365171)
92. Bochaton-Piallat, M. L., Kapetanios, A. D., Donati, G., Redard, M., Gabbiani, G., Pournaras, C. J: TGF-β1, TGF-β receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 41, 2336-2342 (2000) (Pubitemid 30451011)
93. Connor, T. B. Jr., Roberts, A. B., Sporn, M. B., Danielpour, D., Dart, L. L., Michels, R. G., de Bustros, S., Enger, C., Kato, H., Lansing, M: Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 83, 1661-6 (1989) (Pubitemid 19124123)
94. Roberts, A. B., Tian, F., Byfield, S. D., Stuelten, C., Ooshima, A., Saika, S., Flanders, K. C: Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17, 19-27 (2006) (Pubitemid 43117513)
95. Jaffe, G. J., Harrison, C. E., Lui, G. M., Roberts, W. L., Goldsmith, P. C., Mesiano, S., Jaffe, R. B: Activin expression by cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 35, 2924-2931 (1994) (Pubitemid 24186394)
96. Choudhury, P., Chen, W: Hunt R. C. Production of platelet-derived growth factor by interleukin-1β and transforming growth factor-β-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest Ophthalmol Vis Sci 38, 824-833 (1997) (Pubitemid 27193507)
97. Cassidy, L., Barry, P., Shaw, C., Duffy, J., Kennedy, S: Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82, 181-185 (1998) (Pubitemid 28176995)
98. Carrington, L., McLeod, D., Boulton, M: IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction. Invest Ophthalmol Vis Sci 41, 1210-1216 (2000) (Pubitemid 30187562)
99. Hinton, D. R., He, S., Jin, M. L., Barron, E., Ryan, S. J: Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16, 422-428 (2002) (Pubitemid 34845970)
100. Hirase, K., Ikeda, T., Sotozono, C., Nishida, K., Sawa, H., Kinoshita, S: Transforming growth factor β2 in the vitreous in proliferative diabetic retinopathy. Arch Ophthalmol 116, 738-741 (1998) (Pubitemid 28292726)
101. Saika, S., Ikeda, K., Yamanaka, O., Sato, M., Muragaki, Y., Ohnishi, Y., Ooshima, A., Nakajima, Y., Namikawa, K., Kiyama, H., Flanders, K. C., Roberts, A. B: Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest 84, 1245-1258 (2004)
102. Saika, S., Yamanaka, O., Ishida-Nishikawa, I., Kitano, A., Flanders, K. C., Okada, Y., Ohnishi, Y., Nakajima, Y., Ikeda, K: Smad7 gene overexpression suppresses TGFβ-induced retinal pigment fibrosis in a PVR mouse model. Arch Ophthalmol 125, 647-654 (2007)
103. Saika, S., Kono-Saika, S., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Flanders, K. C., Yoo, J., Anzono, M., Liu, C.-Y., Kao, W. W.-Y., Roberts, A. B: Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 164, 651-663 (2004) (Pubitemid 38364679)
104. Saika, S., Kono-Saika, S., Tanaka, T., Yamanaka, O., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Yoo, J., Flanders, K. C., Roberts, A. B: Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest 84, 1259-1270 (2004)
105. Leung, E. W., Rife, L., Smith, R. E., Kay, E. P: Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemet's membrane. Mol Vis 6, 15-23 (2000)
106. Kroll P, Rodrigues EB, Hoerle S: Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 221, 78-94 (2007) (Pubitemid 46465433)
107. Simó R, Carrasco E, García-Ramírez M, Hernández C: Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2, 71-98 (2006) (Pubitemid 44082952)
108. Ban CR, Twigg SM: Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 4, 575-96 (2008) (Pubitemid 352037917)
109. Li D, Zhang C, Song F, Lubenec I, Tian Y, Song QH: VEGF regulates FGF-2 and TGF-β1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration. Microvasc Res (2008) (in press)
110. Inagaki, Y., Kushida, M., Higashi, K., Itoh, J., Higashiyama, R., Hong, Y. Y., Kawada, N., Namikawa, K., Kiyama, H., Bou-Gharios, G., Watanabe, T., Okazaki, I., Ikeda, K: Cell type-specific intervention of transforming growth factor β/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 129, 259-268 (2005) (Pubitemid 41002059)
111. Yamanaka, O., Ikeda, K., Saika, S., Miyazaki, K., Ooshima, A., Ohnishi, Y: Gene transferr of Smad7 modulates injury-induced conjunctival wound healing. Mol Vis 12, 841-851 (2006) (Pubitemid 44151616)
112. Campochiaro, P. A., Nguyen, Q. D., Shah, S. M., Klein, M. L., Holz, E., Frank, R. N., Saperstein, D. A., Gupta, A., Stout, J. T., Macko, J., DiBartolomeo, R., Wei, L. L: Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther 17, 167-76 (2006) (Pubitemid 43262032)
113. Saika S, Ikeda K, Yamanaka O, Flanders KC, Nakajima Y, Miyamoto T, Ohnishi Y, Kao WW, Muragaki Y, Ooshima A: Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab Invest 85, 474-86 (2005) (Pubitemid 40523940)
114. Sumioka T, Ikeda K, Okada Y, Yamanaka O, Kitano A, Saika S: Inhibitory effect of blocking TGF-β/Smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis 14, 2272-2281 (2008)
115. Zeisberg, M., Hanai, J., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., Kalluri, R: BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9, 964-968 (2003) (Pubitemid 36889942)
116. Zeisberg, M., Kalluri, R: The role of epithelial-tomesenchymal transition in renal fibrosis. J Mol Med 82, 175-81 (2004) (Pubitemid 38392167)
117. Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C. H., Moustakas, A: Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein. Mol Cell Biol 24, 4241-4254 (2004) (Pubitemid 41070996)
118. Saika, S., Yamanaka, O., Ikeda, K., Kim-Mitsuyama, S., Flanders, K. C., Yoo, J., Roberts, A. B., Nishikawa-Ishida, I., Ohnishi, Y., Muragaki, Y., Ooshima, A: Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest 85, 838-850 (2005) (Pubitemid 41021293)
119. Mori, Y., Chen, S. J., Varga, J: Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res 258, 374-383 (2000) (Pubitemid 30483515)
120. Yoon, P. S., Singh, K: Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol 15, 141-146 (2004) (Pubitemid 38457135)
121. Ishida, W., Mori, Y., Lakos, G., Sun, L., Shan, F., Bowes, S., Josiah, S., Lee, W. C., Singh, J., Ling, L. E., Varga, J: Intracellular TGF-β receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo. J Invest Dermatol 126, 1733-44 (2006) (Pubitemid 44086506)
122. Li, J., Campanale, N. V., Liang, R. J., Deane, J. A., Bertram, J. F., Ricardo, S. D: Inhibition of p38 mitogenactivated protein kinase and transforming growth factor-β1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. Am J Pathol 169, 1527-40 (2006) (Pubitemid 351181986)
123. Pannu, J., Nakerakanti, S., Smith, E., ten Dijke, P., Trojanowska, M: Transforming growth factor-P receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathw ays. J Biol Chem 282, 10405-13 (2007) (Pubitemid 47093454)
124. Xavier, S., Piek, E., Fujii, M., Javelaud, D., Mauviel, A., Flanders, K. C., Samuni, A. M., Felici, A., Reiss, M., Yarkoni, S., Sowers, A., Mitchell, J. B., Roberts, A. B., Russo, A: Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem 279, 15167-76 (2004) (Pubitemid 38618912)
125. Kitano, A., Saika, S., Yamanaka. O., Ikeda, K., Reinach, P. S., Nakajima, Y., Okada, Y, Shirai, K., Ohnishi, Y: Effects of genipin on the behaviors of human subconjunctival fibroblasts in vitro. Ophthalmic Res 38, 355-360 (2006)
126. Kitano, A., Saika, S., Yamanaka, O., Reinach, P. S., Ikeda, K., Okada, Y, Shirai, K., Ohnishi, Y: Genipin suppression of fibrogenic behaviors of the a-TN4 lens epithelial cell line. J Cataract Refract Surg 32, 1727-1735 (2006) (Pubitemid 44468012)
127. Kitano, A., Saika, S., Yamanaka, O., Ikeda, K, Okada, Y, Shirai, K, Reinach, P. S: Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci. 48, 5013-22 (2007) (Pubitemid 351260911)